917
Participants
Start Date
February 20, 2017
Primary Completion Date
September 15, 2017
Study Completion Date
October 12, 2017
Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution
Supplied as two 160 mL ready-to-drink bottles, per subject, without further reconstitution, before administration.
Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder
Supplied as two sachets per subject. Subjects will be instructed to reconstitute the medication by combining the contents of one packet with approximately five (5) ounces of cold water and stirring for two to three minutes.
Long Island Gastrointestinal Research Group LLC, Great Neck
Hillmont GI, Flourtown
Wake Research Associates, LLC, Raleigh
Kinston Medical Specialists, PA, Kinston
Florida Clinical Research Group, Clearwater
Nature Coast Clinical Research, Inverness
Clinical Research Associates, Huntsville
Advanced Research Institute, Ogden
GW Research, Inc., Chula Vista
Precision Research Institute, San Diego
Associated Gastroenterology Medical Group, Anaheim
Connecticut Clinical Research Foundation, Bristol
Hotel Dieu Hospital, Kingston
Canadian Phase Onward, Inc., Toronto
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY